Home / Articles Posted by V Pharma Horizon (Page 11)
V Pharma Horizon 153POSTS

vsquaretechno8@gmail.com

The revolutionary gene-editing tool CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) has captivated the scientific world with its potential to rewrite the genetic code

0

The COVID-19 pandemic was a watershed moment for messenger RNA (mRNA) technology. Once confined to academic research and small-scale biotech development, mRNA burst into

0

In an industry where patient safety is paramount, pharmacovigilance (PV)—the science of detecting, assessing, and preventing adverse drug reactions (ADRs)—plays a crucial role in

0

The global pharmaceutical trade, vital to public health and economic stability, is increasingly vulnerable to supply chain disruptions. From geopolitical tensions and natural disasters

0

In the wake of global disruptions—from pandemics and geopolitical tensions to raw material shortages—the pharmaceutical industry has come to recognize the urgent need for

0

In the ever-evolving landscape of drug development, CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) technology has emerged as a transformative force. By enabling precise

0

In an era defined by rapid scientific advances, escalating healthcare costs, and global health threats, the biopharmaceutical industry is undergoing a pivotal transformation. At

0

The COVID-19 pandemic upended global supply chains, exposing critical vulnerabilities and reshaping how industries view resilience, flexibility, and risk management. In the pharmaceutical sector

0

The road from molecule to medicine is long, costly, and fraught with failure. One of the most resource-intensive stages is preclinical testing, where promising

0

In a rapidly evolving pharmaceutical landscape, where personalized medicine and agile supply chains are gaining momentum, 3D printing has emerged as a transformative force—not

0